Sun Pharma R&D arm announces new drug trials
Sun Pharma R&D arm announces new drug trials. The company approved initiation of Phase II clinical trials for SPARC-021, a novel dermatological compound. Board also approved ₹75 crore funding for R&D expansion. This move strengthens its innovation pipeline in specialty dermatology.
📊 STOCKS: $SPARC | 🏢 SECTOR: Pharma | #MEDIUMIMPACT #R&D
This brief is AI-generated from public news sources for informational purposes only. Not investment advice. Always consult a SEBI-registered advisor before trading.